TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells

CRISPR/Cas9 mediated gene editing of patient-derived hematopoietic stem and progenitor cells (HSPCs) ex vivo followed by autologous transplantation of the edited HSPCs back to the patient can provide a potential cure for monogenic blood disorders such as β-hemoglobinopathies. One challenge for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Jonathan, Fiorino, Michael, Liu, Yi, Paula, Steve, Clarkson, Scott, Quinn, Lisa, Tschantz, William R., Klock, Heath, Guo, Ning, Russ, Carsten, Yu, Vionnie W. C., Mickanin, Craig, Stevenson, Susan C., Lee, Cameron, Yang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214993/
https://www.ncbi.nlm.nih.gov/pubmed/30389991
http://dx.doi.org/10.1038/s41598-018-34601-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214993/
https://www.ncbi.nlm.nih.gov/pubmed/30389991
http://dx.doi.org/10.1038/s41598-018-34601-6

Ejemplares similares